CLEC4D and neoplasm: Patients with more advanced CRC tumors show significantly lower Dectin-3 expressions, and CRC patients with higher fecal fungal burden exhibit lower Dectin-3 expression, higher levels of IL-22 in tumor tissues and poorer disease-free survival and overall survival (159).